NHRC Investigates Deadly Pharma Reactor Blast in Andhra Pradesh

The National Human Rights Commission (NHRC) of India has taken suo motu cognizance of a deadly reactor blast at a pharmaceutical company in Andhra Pradesh's Anakapalli. At least 17 workers died and 50 others were injured. A thorough investigation has been ordered to determine the cause and safety compliance.

The National Human Rights Commission (NHRC) of India has initiated an investigation into a tragic reactor blast at a pharmaceutical company in Anakapalli, Andhra Pradesh, following media reports of the incident. The blast, which occurred on August 21 in a private industrial unit at Atchutapuram Special Economic Zone, resulted in the deaths of at least 17 workers and injured 50 others.

The NHRC, upon reviewing the media coverage, noted that there appears to be a violation of the victims' right to life due to negligence by the concerned authorities. Consequently, it has issued notices to Andhra Pradesh's Chief Secretary and Director General of Police, demanding a comprehensive investigation to ascertain whether all safety and legal protocols were observed by the industrial unit's owner and overseen by relevant authorities. The Commission has requested a detailed report within two weeks.

Currently, the State Disaster Response Force teams are combing through the debris for any potential survivors. However, there are fears that the death toll could rise as more bodies may be trapped. The NHRC has also requested updates on the status of the FIR, medical treatment of the injured, compensation disbursement, and relief efforts for the families of the deceased. Additionally, action against any officials found negligent in their duties has been mandated. (ANI)

(With inputs from agencies.)